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a b s t r a c t
The molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae (KPC) has
been largely investigated, but limited clinical information is available. A case-control study
was performed to evaluate the risk factors for KPCbacteremia inhospitalized patients. Cases
were patients with KPC bacteremia and controls were patients with non-KPC bacteremia.
A total of 85 patients were included, 18 (21.2%) were KPC, and 67 (78.8%) were non-KPC (40
[59.7%] of them were extended-spectrum beta-lactamase producers). All KPC isolates were
type 2 producers. These isolates belong to ﬁve distinct clones. Multivariate analysis showed
that age (odds ratio [OR], 1.06; 95% conﬁdence interval [CI], 1.02 – 1.11; p = 0.004), presence
of mechanical ventilation (OR, 11.1; 95% CI, 1.92 – 63.3; p = 0.007) and ﬂuoroquinolone expo-
sure during hospitalization (OR, 28.9; 95% CI, 1.85 – 454.6; p = 0.02) were independent risk
factors for KPC in patients with K. pneumoniae bacteremia. Factors associated with severityof illness, such as age and mechanical ventilation, seem to be the main risks factors for KPC.
Fluoroquinolones use might be a risk factor for KPC bacteremia. Further investigations on
risk factors for KPC are warranted.
Although the molecular epidemiology of KPC isolates has
12 EIntroduction
Klebsiella pneumoniae are major nosocomial pathogens, par-
ticularly those producing extended-spectrum beta-lactamase
1
© 20(ESBL). ESBL producers are usually susceptible only to car-
bapenems, and these drugs have been the treatment of choice
for severe infections by ESBL-producer K. pneumoniae.1 More
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Este é um artigo Open Access sob a licençarecently, the emergence of carbapenemase-producing Kleb-
siella pneumoniae (KPC) has severely challenged antimicrobial
therapy, since it confers a high level of resistance to all beta-
lactams and distinct levels of resistance to carbapenems.2
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been largely investigated, clinical aspects, including risk fac-
tors for infections by these organisms, have been poorly
investigated so far.3,4 From a clinical and epidemiological
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erspective, identiﬁcation of factors associated with KPC in
atients with K. pneumoniae bacteremia is very important for
oth understanding the determinants of the dissemination of
hese organisms and potentially guiding empirical antimicro-
ial choice in severe infections by these organisms, such as
loodstream infections, which is critical for patient outcome.5
his study aimed to assess the risk factors for KPC in hospi-
alized patients with K. pneumoniae bacteremia.
ethods
tudy design
nested case-control study was performed at the Hospital
niversitário Evangélico de Curitiba, a 660-bed tertiary-care
ospital in Curitiba, Brazil. All patients ≥18 years of age with a
ositive blood culture with K. pneumoniae from January 2006 to
ugust 2011 were included in the study. Only one episode per
atientwas analyzed. Datawere collected frommedical charts
nd/or hospital computerized system databases, except for
ase patients, whose data were prospectively collected. The
tudy was approved by the local ethics review board.
icrobiological procedures
ultures were collected according to the standard proto-
ol used in the hospital, and were processed using the
ACT/Alert® (bioMérieux – Durham, USA). K. pneumoniae was
dentiﬁed by Vitek 2 (bioMérieux – Marcy’ Étoile, France).
usceptibility testing was performed by the disk diffusion
ethod according to the CLSI guidelines.6 Detection of ESBL
as determined by disk diffusion method according to CLSI
ecommendation.6 Isolates showing reduced susceptibility to
rtapenem (zone diameter <20mm) were tested for detection
f carbapenemase production using the modiﬁed Hodge test
MHT).6 Isolates with positive MHT were submitted to PCR for
laKPC using EasyQ KPC (bioMérieux – Marcy L’Étoile, France)
ith Escherichia coli ATCC 25922 and blaKPC-carrying K. pneumo-
iae strain ATCC BAA-1705 as negative and positive controls,
espectively. The ampliﬁed product was puriﬁed using Exonu-
lease I and Shrimp Alkaline Phosphatase (ExoSAP, USB
orporatin) for DNA sequencing. Sequencing reactions were
erformed using BigDye v1.1 Sequencing Kits (Applied Biosys-
ems – Foster City, CA, USA). Sequence data were acquired on
BI 3100 (Applied Biosystems – Foster City, CA, USA). The gene
equences were compared to entries in databases queried by
CBI BLAST (nucleotide sequence database).
KPC isolates were examined using automated rep-PCR-
ased typing system (DiversiLabTM, bioMérieux – Athens, GA,
SA).7 The results were analyzed and interpreted with the
iversiLab web-bases software using Pearson’s correlation
ethod. Clonally related isolates were deﬁned as those with
95% homology.
ariables and deﬁnitionsases were deﬁned as patients with KPC bacteremia and
ontrols were patients with non-KPC bacteremia. Potential
isk factors assessed were: gender, age, previous hospital2;16(5):416–419 417
admission within the last 90 days, admission to the inten-
sive care unit, length of hospitalization before bacteremia,
use of mechanical ventilation, presence of central venous line
and/or urinary catheter, surgery during current hospitaliza-
tion, underlying comorbid conditions, and previous antibiotic
use during current hospitalization.
Statistical analysis
All statistical analyses were carried out using the Statistical
Package for Social Sciences (SPSS) for Windows, Version 18.0.
Univariate analysis was performed separately for each vari-
able. P-values were calculated using the chi-squared test or
Fisher’s exact test for categorical variables, andStudent’s t-test
or Wilcoxon rank-sum test for continuous variables. Variables
for which the p-value was ≤ 0.10 in the univariate analysis
were included in a forward stepwise logistic regression model.
Variables were checked for confounding and collinearity. A p-
value of 0.05 was set as the limit for acceptance or removal of
the new terms in the model. Goodness-of-ﬁt was assessed by
the Hosmer–Lemeshow test. All tests were two-tailed, and a
p-value ≤ 0.05 was considered signiﬁcant.
Results
From a total of 932 modiﬁed Hodge tests performed in the
period, 763were truepositives, 19were false positives, 129 true
negative, four were false negative, and 17 were inconclusive.
This test showed 99.5% sensitivity and 87.1% speciﬁcity. The
positive predictive valuewas 96.9%and thenegative predictive
value was 87.1%.
A total of 85patientswere included in this study. 18patients
(21.2%) had KPC bacteremia and 67 (78.8%) had non-KPC bac-
teremia (40 [59.7%] of them were ESBL-producers). All KPC
isolates were type 2 producers. These isolates belong to ﬁve
distinct clones: four isolates, clone 1; three isolates, clone 2;
three isolates, clone 3; ﬁve isolates, clone 4, and one isolate,
clone 5 (Fig. 1). Two isolates could not be typed.
The univariate analysis for KPC bacteremia is presented in
Table 1. Multivariate analysis showed that age (odds ratio [OR],
1.06; 95% conﬁdence interval [CI], 1.02-1.11; p = 0.004), pres-
ence of mechanical ventilation (OR, 11.1; 95% CI: 1.92-63.3; p =
0.007), and ciproﬂoxacin exposure during hospitalization (OR,
28.9; 95% CI: 1.85-454.6; p = 0.02) were independent risk factors
for KPC in patients with K. pneumoniae bacteremia (Hosmer-
Lemeshow 2 test = 4.266. p = 0.832).
Discussion
Carbapenemase producing (CP) Enterobacteriaceae have
become endemic in many regions worldwide, especially
among K. pneumoniae isolates.2 So far, ten types of CP have
been described,8 but type 2 CP is by far the most frequently
described.2 The molecular epidemiology of KPC has been
broadly investigated and theworldwide dissemination ofmul-
9tiple clones, notably ST-258, has been clearly demonstrated.
Additionally, knowledge on genes codifying these enzymes
and surrounding genetic structures has also been advancing
signiﬁcantly.2 However, despite these advances, the clinical
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f 16Fig. 1 – Klebsiella pneumoniae (KPC) clone analysis o
epidemiology of CP-producing organisms has been less
investigated. To date, only one study has investigated the
risk factors for KPC,4 and another has investigated the risk
factors for KPC and metallo-beta-lactamases-producing K.
pneumoniae bacteremia.3 In this study, the risk factors for KPC
were assessed in patients with K. pneumoniae bloodstream
infections.
This study found that advanced age, mechanical venti-
lation, and previous exposure to ciproﬂoxacin were inde-
pendently associated with increased risk for KPC in this
population.
Advanced age has not been found as a risk factor for KPC in
previous studies, but it has been shown that severity of illness,
as determined by the All Patient Reﬁned-Diagnosis Related
Group method or by the APACHE II score,3 was independently
associated with KPC recovery and bacteremia, respectively.
Since it was not possible to assess any score of severity of ill-
ness as a potential risk factor, age is believed to have been
a surrogate marker of such condition, as it might also be in
the case of mechanical ventilation. Interestingly, no previ-
ous study has found carbapenems exposure as a risk factor
for KPC.3,4 Indeed, it was forced into the ﬁnal multivariate
model without modifying the results (data not shown). Actu-
ally, Mouloudi et al. found no antimicrobial class exposure as a
risk factor for KPC bacteremia.3 Conversely, Gasink et al. found
that prior use of an extended-spectrum cephalosporin and
4ciproﬂoxacin were both independently associated with KPC.
Fluoroquinolones (all received ciproﬂoxacin, data not
shown) were found to be an independent risk factor, whichisolates from patients with bloodstream infection.
might be explained by the fact that plasmid-encoded qnr
genes, which determine low-level ﬂuoroquinolone resistance,
have been identiﬁed in the same conjugative K. pneumo-
nia plasmid as CP genes (speciﬁcally blaKPC-2 and qnrB4).10
Although this factor remained independently associated with
outcome and is corroborated by a previous study, caution is
recommendedwhen interpreting andgeneralizing thepresent
ﬁndings, since the exposure rate to this drug in control
patients was extremely low (1.5%).
This study has some limitations that must be acknowl-
edged. First, data from control patients were retrospectively
recovered, and some important variables such as scores for
severity of illness could not be precisely assessed. However, as
discussed above, age and mechanical ventilation are believed
to be surrogate markers of severity, which seems to be an
important risk for KPC. Additionally, although many variables
were associated with the outcome in univariate analysis, the
number of patients included in the study might have reduced
the statistical power to detect minor differences between
groups for some variables. Finally, carbapenem exposure may
have not been found as a risk for KPC bacteremia because pre-
vious antimicrobial exposurewas consideredduring the entire
admission period. Thus, it is possible that numerous control
patients received a carbapenem drug many days before the
recovery of K. pneumoniae from blood. In fact, recent exposures
to antimicrobials are usually more frequently associated with
11the recovery of resistant bacteria.
In summary, this was the second study designed to assess
risk factors for KPC bacteremia. Factors associated with
braz j infect d i s . 201
Table 1 – Univariate analysis of risk factors for






Age, years 60.4 ± 14.0 48.2 ± 16.6 0.005
Gender, male 11 (61.1) 38 (56.7) 0.95
Comorbidities
Cardiovascular 3 (16.7) 28 (41.8) 0.04
Malignancy 3 (16.7) 9 (13.4) 0.49
Diabetes 10 (55.6) 17 (25.4) 0.03
Renal 1 (5.6) 10 (14.9) 0.27
Trauma 5 (27.8) 15 (22.4) 0.87
Previous surgery 7 (38.9) 38 (56.7) 0.28
Intensive care unit stay 14 (77.8) 44 (65.7) 0.25
Mechanical ventilation 16 (88.9) 34 (50.7) 0.003
Length of hospital stay* 28 (16–75) 32 (17–63) 0.99
Previous hospital admission 5 (27.8) 20 (29.9) 0.91
Antibiotic exposure
Carbapenems 8 (44.4) 20 (29.9) 0.38
Cefepime 2 (11.1) 18 (26.9) 0.14
Ceftriaxone 4 (22.2) 10 (14.9) 0.34
Fluorquinolones 4 (22.2) 1 (1.5) 0.007
Vancomycin 4 (22.2) 13 (19.4) 0.51
Metronidazol 4 (22.2) 9 (13.4) 0.30
Presence of device
Urinary catheter 17 (94.4) 44 (45.7) 0.01
Central venous catheter 17 (94.4) 36 (53.7) 0.001





















∗ Median (percentile 25%–75%).
everity of illness, such as age and mechanical ventilation,
eem to be the main risks factors for KPC, as also indicated
y previous studies. Fluoroquinolones might be a risk factor
or KPC bacteremia. Further investigations on risk factors for
PC are required to better understand the epidemiological
eterminants of the dissemination of these organisms and to
ptimize empirical therapy for high-risk group in settingswith
igh prevalence of KPC.
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